Previous 10 | Next 10 |
The following slide deck was published by Hologic, Inc. in conjunction with this Read more ...
This article is part of a series that provides an ongoing analysis of the changes made to Kahn Brothers’ 13F stock portfolio on a quarterly basis. It is based on Kahn Brothers’ regulatory 13F Form filed on 08/05/2019. Please visit our Tracking Kahn Brothers Portfolio series t...
Quick Take InMode ( INMD ) has filed to raise gross proceeds of $75 million from a U.S. IPO, according to an F-1/A registration statement . The firm provides minimally-invasive surgical aesthetic and medical treatment solutions for physicians. INMD is growing smartly, is profitable and ...
Hologic, Inc. (Nasdaq : HOLX), a global leader in women’s health, and SuperSonic Imagine (Euronext: SSI, FR0010526814), a company specialized in ultrasound medical imaging, jointly announce today that Hologic Hub Ltd, a wholly-owned indirect subsidiary of Hologic, Inc., has acquired ap...
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the Canaccord Genuity 39 th Annual Growth Conference in New York, NY on Wednesday, August 7 at 10 a.m. Eastern Time. The presentation will be webcast live and may be accessed through a link on the investors sec...
Hologic, Inc. (HOLX) Q3 2019 Earnings Conference Call July 31, 2019 04:30 PM ET Company Participants Mike Watts - Vice President, Investor Relations & Corporate Communications Steve MacMillan - Chairman, President & Chief Executive Officer Karleen Oberton - Chief Financia...
Hologic (NASDAQ: HOLX ) fiscal Q3 results ($M): Revenues: 852.4 (+3.4%); Diagnostics: 305.4 (+3.8%); Breast Health: 325.4 (+5.7%). More news on: Hologic, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Hologic (NASDAQ: HOLX ): Q3 Non-GAAP EPS of $0.63 beats by $0.02 ; GAAP EPS of $0.35 in-line. More news on: Hologic, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
– Revenue of $852.4 Million Grows 3.4%, 4.7% in Constant Currency – – Company Posts GAAP Diluted EPS of $0.35, Non-GAAP Diluted EPS of $0.63 – Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal third quarter e...
Hologic ( HOLX +0.3% ) announces the commercial launch of its TempSure Firm handpiece and a petit mask for SculpSure submental (under the chin) treatments. More news on: Hologic, Inc., Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 10:30:04 ET BTIG analyst issues NEUTRAL recommendation for HOLX on July 30, 2024 08:28AM ET. The previous analyst recommendation was Neutral. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...
2024-07-30 09:30:03 ET RBC Capital analyst issues SECTOR PERFORM recommendation for HOLX on July 30, 2024 07:43AM ET. The previous analyst recommendation was Sector Perform. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus ...
– Revenue of $1,011.4 Million, GAAP Diluted EPS of $0.82, and Non-GAAP Diluted EPS of $1.06; All Met or Exceeded Guidance – – Total Company Revenue Growth of 2.7%, or 3.1% in Constant Currency and 5.8% Organically excluding COVID-19; Against Growth of 18.4% in the Prior Y...